0 rating

Epidemiology

Pickin M, Cooper CL, Chater T et al.

University of Sheffield, Sheffield, UK.

 BMC Neurol 2009;9:1.

Editor’s note: Increasing therapeutic opportunities represent greater financial burdens for the health systems concerned. Risk-sharing schemes have thus been developed to balance cost effectiveness and rationing of high-cost health interventions by sharing the financial burden between the UK Department of Health and the pharmaceutical companies responsible for their production.

Return to top

LATEST ARTICLES